WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead’s drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
WHO says remdesivir and three other drugs have no effect on COVID-19 patients
The World Health Organization has said that trial results show remdesivir and three other drugs administered to people infected with the novel coronavirus "have little or no effect" in terms of lowering the morality rate. "Interim results from the Solidarity Therapeutics Trial, coordinated by the ...
Japan approves dexamethasone as second drug for coronavirus treatment
The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market. The drug helped patients ...
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Gilead Sciences Inc. is seeking Japanese regulatory approval for remdesivir, a drug that potentially can reduce the impact of the coronavirus in some patients, according to sources. The health ministry is expected to move quickly and approve remdesivir using a fast-track process that allows for ...
Japan health ministry expediting remdesivir for COVID-19 patients
The health ministry plans to shorten approval time for the Ebola drug after U.S. President Donald Trump said it was cleared for coronavirus patients in America.
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States. During a meeting in the Oval Office ...
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter. Details from a U.S. government study and ...
Hopes rise in virus battle as U.S. scientists hail drug trial
U.S. scientists on Wednesday hailed a potential breakthrough in the coronavirus fight as a trial showed patients responding to an antiviral drug, fueling global hopes for a return to normal despite mounting deaths. In the first proof of successful treatment against the illness that has ...
